Skip to content

Clinical trials

Recruiting Phase 1/2 Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1/2 Status: Recruiting Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20171
20183
20191
20203
20211
20224
202312
202410
202512
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting55

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Revolution Medicines, Inc.3
A2 Biotherapeutics Inc.2
Bristol-Myers Squibb2
Essen Biotech2
National Cancer Institute (NCI)2
Tango Therapeutics, Inc.2
University of Saskatchewan2
Vanderbilt-Ingram Cancer Center2
3H Pharmaceuticals Co., Ltd.1
Auricula Biosciences Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms55
Carcinoma, Non-Small-Cell Lung30
Colorectal Neoplasms19
Pancreatic Neoplasms17
Neoplasm Metastasis12
Neoplasms12
Stomach Neoplasms11
Breast Neoplasms10
Head and Neck Neoplasms10
Melanoma9

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.